FDA Panel Scheduled to Review Second Sight’s Argus II Retinal Prosthesis System

Second Sight Medical Products announced that an FDA Ophthalmic Devices Advisory Panel has been scheduled to review the data presented in the company’s HDE market approval application for its Argus II Retinal Prosthesis System.
MarketWatch